The prevalence of sight-threatening uveitis in Scotland
Aim: To identify and quantify the prevalence of patients with uveitis receiving systemic immunosuppression in Scotland. Methods: Anonymised data were prospectively collected on all patients with uveitis requiring systemic immunosuppression. Seven health boards participated over a 4-month period betw...
Gespeichert in:
Veröffentlicht in: | British journal of ophthalmology 2007-01, Vol.91 (1), p.33-36 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 36 |
---|---|
container_issue | 1 |
container_start_page | 33 |
container_title | British journal of ophthalmology |
container_volume | 91 |
creator | Williams, G J Brannan, S Forrester, J V Gavin, M P Paterson-Brown, S P Purdie, A T Virdi, M Olson, J A |
description | Aim: To identify and quantify the prevalence of patients with uveitis receiving systemic immunosuppression in Scotland. Methods: Anonymised data were prospectively collected on all patients with uveitis requiring systemic immunosuppression. Seven health boards participated over a 4-month period between 1 August 2005 and 30 November 2005. Results: 373 patients were identified, of whom 205 (55%) were female. The mean age was 46.4 (range 7–97 years). Using the data from the seven participating health boards, an estimated Scottish prevalence of 9 per 100 000 was calculated. Prevalence varied between 2 and 59 per 100 000. In National Health Service Grampian, all patients with uveitis, whether sight-threatening or not, are followed up at a specialist clinic. Extrapolating this figure to Scotland gives a prevalence of 25 per 100 000. Discussion: The data from National Health Service Grampian suggest that there is a significant shortfall in the number of patients identified by survey. If the “missing population” exists, then where are they? Some might be receiving appropriate treatment at non-specialist clinics, although simple under-reporting may play a part. Greater concern is for those patients receiving inappropriate treatment for their uveitis, or for those within the community who are either oblivious to or in self denial of their condition. |
doi_str_mv | 10.1136/bjo.2006.101386 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1857573</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4012419821</sourcerecordid><originalsourceid>FETCH-LOGICAL-b588t-de5738b9662b3441ef79aecfcd36ff6730311747bf1720ecc84429bf7da692303</originalsourceid><addsrcrecordid>eNqFkcFv0zAUxi0EYt3gzA1FQnCYlM4vdmznggQVA6RRDgyuluM8ty5pUuykGv_9XKXa2C6cLOv9_L3v80fIK6BzACYu6k0_LygVc6DAlHhCZsCFygsqq6dkRimVOYCAE3Ia4yZdCwHyOTkBUYFQUsyIvF5jtgu4Ny12FrPeZdGv1kM-rAOaATvfrbJxj37wMfNd9sP2Q2u65gV55kwb8eXxPCM_Lz9dL77kV98_f118uMrrUqkhb7CUTNWVEEXNOAd0sjJonW2YcE5IRhmA5LJ2IAuK1irOi6p2sjGiKtL0jLyfdHdjvcXGYjcE0-pd8FsT_ureeP1w0vm1XvV7DaqUaXcSeHcUCP2fEeOgtz5abFMI7MeohWKKcSYT-OYRuOnH0KVwGqRUVcGlKhN1MVE29DEGdHdWgOpDJTpVog-V6KmS9OL1vwnu-WMHCXh7BEy0pnXBdNbHey7ZUyU_rM4nzscBb-7mJvzW6SNlqZe_Flpdflsulh-Z5ok_n_h6u_mvy1siZ6_k</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1778924785</pqid></control><display><type>article</type><title>The prevalence of sight-threatening uveitis in Scotland</title><source>MEDLINE</source><source>BMJ Journals - NESLi2</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Williams, G J ; Brannan, S ; Forrester, J V ; Gavin, M P ; Paterson-Brown, S P ; Purdie, A T ; Virdi, M ; Olson, J A</creator><creatorcontrib>Williams, G J ; Brannan, S ; Forrester, J V ; Gavin, M P ; Paterson-Brown, S P ; Purdie, A T ; Virdi, M ; Olson, J A ; on behalf of the Scottish Uveitis Network</creatorcontrib><description>Aim: To identify and quantify the prevalence of patients with uveitis receiving systemic immunosuppression in Scotland. Methods: Anonymised data were prospectively collected on all patients with uveitis requiring systemic immunosuppression. Seven health boards participated over a 4-month period between 1 August 2005 and 30 November 2005. Results: 373 patients were identified, of whom 205 (55%) were female. The mean age was 46.4 (range 7–97 years). Using the data from the seven participating health boards, an estimated Scottish prevalence of 9 per 100 000 was calculated. Prevalence varied between 2 and 59 per 100 000. In National Health Service Grampian, all patients with uveitis, whether sight-threatening or not, are followed up at a specialist clinic. Extrapolating this figure to Scotland gives a prevalence of 25 per 100 000. Discussion: The data from National Health Service Grampian suggest that there is a significant shortfall in the number of patients identified by survey. If the “missing population” exists, then where are they? Some might be receiving appropriate treatment at non-specialist clinics, although simple under-reporting may play a part. Greater concern is for those patients receiving inappropriate treatment for their uveitis, or for those within the community who are either oblivious to or in self denial of their condition.</description><identifier>ISSN: 0007-1161</identifier><identifier>EISSN: 1468-2079</identifier><identifier>DOI: 10.1136/bjo.2006.101386</identifier><identifier>PMID: 16916876</identifier><identifier>CODEN: BJOPAL</identifier><language>eng</language><publisher>BMA House, Tavistock Square, London, WC1H 9JR: BMJ Publishing Group Ltd</publisher><subject>Adolescent ; Adult ; Age ; Age Distribution ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Blindness - etiology ; Child ; Clinical Science - Scientific Report ; Data collection ; Female ; Humans ; Immunosuppression Therapy ; Male ; Medical personnel ; Medical sciences ; Middle Aged ; Miscellaneous ; National Health Service ; NHS ; Ophthalmology ; Population ; Prevalence ; Prospective Studies ; Scotland - epidemiology ; Sex Distribution ; Uvea diseases ; Uveitis - complications ; Uveitis - epidemiology ; Uveitis - immunology ; Visual impairment ; Workloads</subject><ispartof>British journal of ophthalmology, 2007-01, Vol.91 (1), p.33-36</ispartof><rights>Copyright 2007 British Journal of Ophthalmology</rights><rights>2007 INIST-CNRS</rights><rights>Copyright: 2007 Copyright 2007 British Journal of Ophthalmology</rights><rights>Copyright © 2007 BMJ Publishing Group</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b588t-de5738b9662b3441ef79aecfcd36ff6730311747bf1720ecc84429bf7da692303</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://bjo.bmj.com/content/91/1/33.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://bjo.bmj.com/content/91/1/33.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,230,314,723,776,780,881,3183,23550,27901,27902,53766,53768,77343,77374</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18348545$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16916876$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Williams, G J</creatorcontrib><creatorcontrib>Brannan, S</creatorcontrib><creatorcontrib>Forrester, J V</creatorcontrib><creatorcontrib>Gavin, M P</creatorcontrib><creatorcontrib>Paterson-Brown, S P</creatorcontrib><creatorcontrib>Purdie, A T</creatorcontrib><creatorcontrib>Virdi, M</creatorcontrib><creatorcontrib>Olson, J A</creatorcontrib><creatorcontrib>on behalf of the Scottish Uveitis Network</creatorcontrib><title>The prevalence of sight-threatening uveitis in Scotland</title><title>British journal of ophthalmology</title><addtitle>Br J Ophthalmol</addtitle><description>Aim: To identify and quantify the prevalence of patients with uveitis receiving systemic immunosuppression in Scotland. Methods: Anonymised data were prospectively collected on all patients with uveitis requiring systemic immunosuppression. Seven health boards participated over a 4-month period between 1 August 2005 and 30 November 2005. Results: 373 patients were identified, of whom 205 (55%) were female. The mean age was 46.4 (range 7–97 years). Using the data from the seven participating health boards, an estimated Scottish prevalence of 9 per 100 000 was calculated. Prevalence varied between 2 and 59 per 100 000. In National Health Service Grampian, all patients with uveitis, whether sight-threatening or not, are followed up at a specialist clinic. Extrapolating this figure to Scotland gives a prevalence of 25 per 100 000. Discussion: The data from National Health Service Grampian suggest that there is a significant shortfall in the number of patients identified by survey. If the “missing population” exists, then where are they? Some might be receiving appropriate treatment at non-specialist clinics, although simple under-reporting may play a part. Greater concern is for those patients receiving inappropriate treatment for their uveitis, or for those within the community who are either oblivious to or in self denial of their condition.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age</subject><subject>Age Distribution</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Blindness - etiology</subject><subject>Child</subject><subject>Clinical Science - Scientific Report</subject><subject>Data collection</subject><subject>Female</subject><subject>Humans</subject><subject>Immunosuppression Therapy</subject><subject>Male</subject><subject>Medical personnel</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Miscellaneous</subject><subject>National Health Service</subject><subject>NHS</subject><subject>Ophthalmology</subject><subject>Population</subject><subject>Prevalence</subject><subject>Prospective Studies</subject><subject>Scotland - epidemiology</subject><subject>Sex Distribution</subject><subject>Uvea diseases</subject><subject>Uveitis - complications</subject><subject>Uveitis - epidemiology</subject><subject>Uveitis - immunology</subject><subject>Visual impairment</subject><subject>Workloads</subject><issn>0007-1161</issn><issn>1468-2079</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkcFv0zAUxi0EYt3gzA1FQnCYlM4vdmznggQVA6RRDgyuluM8ty5pUuykGv_9XKXa2C6cLOv9_L3v80fIK6BzACYu6k0_LygVc6DAlHhCZsCFygsqq6dkRimVOYCAE3Ia4yZdCwHyOTkBUYFQUsyIvF5jtgu4Ny12FrPeZdGv1kM-rAOaATvfrbJxj37wMfNd9sP2Q2u65gV55kwb8eXxPCM_Lz9dL77kV98_f118uMrrUqkhb7CUTNWVEEXNOAd0sjJonW2YcE5IRhmA5LJ2IAuK1irOi6p2sjGiKtL0jLyfdHdjvcXGYjcE0-pd8FsT_ureeP1w0vm1XvV7DaqUaXcSeHcUCP2fEeOgtz5abFMI7MeohWKKcSYT-OYRuOnH0KVwGqRUVcGlKhN1MVE29DEGdHdWgOpDJTpVog-V6KmS9OL1vwnu-WMHCXh7BEy0pnXBdNbHey7ZUyU_rM4nzscBb-7mJvzW6SNlqZe_Flpdflsulh-Z5ok_n_h6u_mvy1siZ6_k</recordid><startdate>20070101</startdate><enddate>20070101</enddate><creator>Williams, G J</creator><creator>Brannan, S</creator><creator>Forrester, J V</creator><creator>Gavin, M P</creator><creator>Paterson-Brown, S P</creator><creator>Purdie, A T</creator><creator>Virdi, M</creator><creator>Olson, J A</creator><general>BMJ Publishing Group Ltd</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><general>BMJ Group</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20070101</creationdate><title>The prevalence of sight-threatening uveitis in Scotland</title><author>Williams, G J ; Brannan, S ; Forrester, J V ; Gavin, M P ; Paterson-Brown, S P ; Purdie, A T ; Virdi, M ; Olson, J A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b588t-de5738b9662b3441ef79aecfcd36ff6730311747bf1720ecc84429bf7da692303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age</topic><topic>Age Distribution</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Blindness - etiology</topic><topic>Child</topic><topic>Clinical Science - Scientific Report</topic><topic>Data collection</topic><topic>Female</topic><topic>Humans</topic><topic>Immunosuppression Therapy</topic><topic>Male</topic><topic>Medical personnel</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Miscellaneous</topic><topic>National Health Service</topic><topic>NHS</topic><topic>Ophthalmology</topic><topic>Population</topic><topic>Prevalence</topic><topic>Prospective Studies</topic><topic>Scotland - epidemiology</topic><topic>Sex Distribution</topic><topic>Uvea diseases</topic><topic>Uveitis - complications</topic><topic>Uveitis - epidemiology</topic><topic>Uveitis - immunology</topic><topic>Visual impairment</topic><topic>Workloads</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Williams, G J</creatorcontrib><creatorcontrib>Brannan, S</creatorcontrib><creatorcontrib>Forrester, J V</creatorcontrib><creatorcontrib>Gavin, M P</creatorcontrib><creatorcontrib>Paterson-Brown, S P</creatorcontrib><creatorcontrib>Purdie, A T</creatorcontrib><creatorcontrib>Virdi, M</creatorcontrib><creatorcontrib>Olson, J A</creatorcontrib><creatorcontrib>on behalf of the Scottish Uveitis Network</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Williams, G J</au><au>Brannan, S</au><au>Forrester, J V</au><au>Gavin, M P</au><au>Paterson-Brown, S P</au><au>Purdie, A T</au><au>Virdi, M</au><au>Olson, J A</au><aucorp>on behalf of the Scottish Uveitis Network</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The prevalence of sight-threatening uveitis in Scotland</atitle><jtitle>British journal of ophthalmology</jtitle><addtitle>Br J Ophthalmol</addtitle><date>2007-01-01</date><risdate>2007</risdate><volume>91</volume><issue>1</issue><spage>33</spage><epage>36</epage><pages>33-36</pages><issn>0007-1161</issn><eissn>1468-2079</eissn><coden>BJOPAL</coden><abstract>Aim: To identify and quantify the prevalence of patients with uveitis receiving systemic immunosuppression in Scotland. Methods: Anonymised data were prospectively collected on all patients with uveitis requiring systemic immunosuppression. Seven health boards participated over a 4-month period between 1 August 2005 and 30 November 2005. Results: 373 patients were identified, of whom 205 (55%) were female. The mean age was 46.4 (range 7–97 years). Using the data from the seven participating health boards, an estimated Scottish prevalence of 9 per 100 000 was calculated. Prevalence varied between 2 and 59 per 100 000. In National Health Service Grampian, all patients with uveitis, whether sight-threatening or not, are followed up at a specialist clinic. Extrapolating this figure to Scotland gives a prevalence of 25 per 100 000. Discussion: The data from National Health Service Grampian suggest that there is a significant shortfall in the number of patients identified by survey. If the “missing population” exists, then where are they? Some might be receiving appropriate treatment at non-specialist clinics, although simple under-reporting may play a part. Greater concern is for those patients receiving inappropriate treatment for their uveitis, or for those within the community who are either oblivious to or in self denial of their condition.</abstract><cop>BMA House, Tavistock Square, London, WC1H 9JR</cop><pub>BMJ Publishing Group Ltd</pub><pmid>16916876</pmid><doi>10.1136/bjo.2006.101386</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-1161 |
ispartof | British journal of ophthalmology, 2007-01, Vol.91 (1), p.33-36 |
issn | 0007-1161 1468-2079 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1857573 |
source | MEDLINE; BMJ Journals - NESLi2; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Adolescent Adult Age Age Distribution Aged Aged, 80 and over Biological and medical sciences Blindness - etiology Child Clinical Science - Scientific Report Data collection Female Humans Immunosuppression Therapy Male Medical personnel Medical sciences Middle Aged Miscellaneous National Health Service NHS Ophthalmology Population Prevalence Prospective Studies Scotland - epidemiology Sex Distribution Uvea diseases Uveitis - complications Uveitis - epidemiology Uveitis - immunology Visual impairment Workloads |
title | The prevalence of sight-threatening uveitis in Scotland |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T07%3A38%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20prevalence%20of%20sight-threatening%20uveitis%20in%20Scotland&rft.jtitle=British%20journal%20of%20ophthalmology&rft.au=Williams,%20G%20J&rft.aucorp=on%20behalf%20of%20the%20Scottish%20Uveitis%20Network&rft.date=2007-01-01&rft.volume=91&rft.issue=1&rft.spage=33&rft.epage=36&rft.pages=33-36&rft.issn=0007-1161&rft.eissn=1468-2079&rft.coden=BJOPAL&rft_id=info:doi/10.1136/bjo.2006.101386&rft_dat=%3Cproquest_pubme%3E4012419821%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1778924785&rft_id=info:pmid/16916876&rfr_iscdi=true |